Monthly Archives: January 2011

ACSI awarded $11 Million from National Resources Canada to commercialize production of 99mTc

The most commonly-used medical isotope, technetium-99m (99mTc) (half-life 6 hours), is derived from its parent, molybdenum-99 (99Mo) (half-life 2.7 days), which is currently produced in a few aging nuclear reactors.  This supply chain is becoming increasingly fragile and when a major reactor is removed from service unexpectedly or for planned maintenance, a world-wide medical isotope shortage may result.